Scott D. Solomon
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Cardiovascular Function and Risk Factors
- Heart Failure Treatment and Management
- Cardiac pacing and defibrillation studies
- Blood Pressure and Hypertension Studies
- Cardiac electrophysiology and arrhythmias
- Endocrinology, Diabetes and Metabolism top 0.01%
- Diabetes Treatment and Management
Papers in
-
- Heart Failure Treatment and Management 300
- Cardiovascular Function and Risk Factors 245
- Cardiac pacing and defibrillation studies 107
- Blood Pressure and Hypertension Studies 36
-
- Diabetes Treatment and Management 99
- Hormonal Regulation and Hypertension 34
- Co-authors
- John J.V. McMurray (251 shared papers)Marc A. Pfeffer (251 shared papers)Brian Claggett (251 shared papers)Karl Swedberg (136 shared papers)Akshay S. Desai (240 shared papers)Michael R. Zile (184 shared papers)Jean L. Rouleau (179 shared papers)Milton Packer (150 shared papers)
- Journals
- European Journal of Heart Failure (155 papers)Journal of the American College of Cardiology (142 papers)Circulation (115 papers)European Heart Journal (100 papers)JACC Heart Failure (87 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Scott D. Solomon
1.1k papers receiving 93.8k citations
Scott D. Solomon's Hit Papers
Peers
Comparison fields: 5 of 195
- Cardiology and Cardiovascular Medicine 51.4k
- Endocrinology, Diabetes and Metabolism 11.0k
- Nephrology 4.0k
- Critical Care and Intensive Care Medicine 1.5k
- Pulmonary and Respiratory Medicine 9.6k
Countries citing papers authored by Scott D. Solomon
This map shows the geographic impact of Scott D. Solomon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Solomon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Solomon more than expected).
Fields of papers citing papers by Scott D. Solomon
This network shows the impact of papers produced by Scott D. Solomon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Solomon. The network helps show where Scott D. Solomon may publish in the future.
Co-authors
The 25 scholars most cited alongside Scott D. Solomon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 1.2k papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology Hit paper breakdown → | 2005 | 9399 |
| 2 | Guidelines for the Echocardiographic Assessment of the Right Heart in Adults: A Report from the American Society of Echocardiography Hit paper breakdown → | 2010 | 5263 |
| 3 | Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure Hit paper breakdown → | 2014 | 4433 |
| 4 | Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events Hit paper breakdown → | 2009 | 2075 |
| 5 | Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome Hit paper breakdown → | 2015 | 1763 |
| 6 | Valsartan, Captopril, or Both in Myocardial Infarction Complicated by Heart Failure, Left Ventricular Dysfunction, or Both Hit paper breakdown → | 2003 | 1680 |
| 7 | Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention Hit paper breakdown → | 2005 | 1572 |
| 8 | Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction Hit paper breakdown → | 2004 | 1506 |
| 9 | A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease Hit paper breakdown → | 2009 | 1441 |
| 10 | Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 Hit paper breakdown → | 2020 | 1431 |
| 11 | Potential Effects of Coronaviruses on the Cardiovascular System Hit paper breakdown → | 2020 | 1258 |
| 12 | The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial Hit paper breakdown → | 2012 | 890 |
| 13 | Cardiorenal End Points in a Trial of Aliskiren for Type 2 Diabetes Hit paper breakdown → | 2012 | 874 |
| 14 | Celecoxib for the Prevention of Colorectal Adenomatous Polyps Hit paper breakdown → | 2006 | 755 |
| 15 | The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial Hit paper breakdown → | 2008 | 645 |
| 16 | Influence of Ejection Fraction on Cardiovascular Outcomes in a Broad Spectrum of Heart Failure Patients Hit paper breakdown → | 2005 | 616 |
| 17 | Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial–Cardiac Resynchronization Therapy (MADIT-CRT) Hit paper breakdown → | 2011 | 557 |
| 18 | Impaired Systolic Function by Strain Imaging in Heart Failure With Preserved Ejection Fraction Hit paper breakdown → | 2013 | 537 |
| 19 | Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both Hit paper breakdown → | 2005 | 534 |
| 20 | SGLT2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomised controlled trials Hit paper breakdown → | 2022 | 530 |
About Scott D. Solomon
Scott D. Solomon is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Epidemiology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 1.2k papers that have together received 96.1k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (300 papers), Cardiovascular Function and Risk Factors (245 papers), Cardiac pacing and defibrillation studies (107 papers), Diabetes Treatment and Management (99 papers), Cardiac Imaging and Diagnostics (43 papers), Blood Pressure and Hypertension Studies (36 papers), Influenza Virus Research Studies (36 papers) and Hormonal Regulation and Hypertension (34 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (51.4k citations), Endocrinology, Diabetes and Metabolism (11.0k citations), Nephrology (4.0k citations), Critical Care and Intensive Care Medicine (1.5k citations) and Pulmonary and Respiratory Medicine (9.6k citations). Scott D. Solomon has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include John J.V. McMurray, Marc A. Pfeffer, Brian Claggett, Karl Swedberg, Akshay S. Desai, Michael R. Zile, Jean L. Rouleau, Milton Packer, Amil M. Shah and Elyse Foster. Their work appears in journals such as European Journal of Heart Failure, Journal of the American College of Cardiology, Circulation, European Heart Journal and JACC Heart Failure.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.